Skip to main content

Get Health Care
About
Giving
Find Faculty
Library
RUSH U Portal
I am a...
Select from the list below to customize your experience: Select a new category

I am a:

Education
Looking to take the next step in your career? RUSH University offers a wide range of education and training options, including nationally ranked academic programs.

Find a Program
- Colleges
- Quick Links
Admissions
Student Life
Experience what life is like at RUSH University, and discover what our supportive learning community has to offer.

Learn More About Student Life
- About the RUSH Experience
- Quick Links
Research
RUSH researchers are leading efforts to cure disease and promote health equity — in Chicago and around the world.

Learn More About Research
- About Our Research
- Quick Links

Get Health Care
About
Giving
Find Faculty
Library
RUSH U Portal
I am a...
Select from the list below to customize your experience: Select a new category

I am a:

Search RUSH University

Lisa Boggio, MD

Breadcrumb

Home
Lisa Boggio, MD

Home

Assistant Professor, Department of Pediatrics

Rush Medical College

Assistant Professor, Department of Pediatrics

Link to Get Care from Lisa Boggio, MD

Pronouns: She/Her

Contact Information

Address: 1725 W. Harrison St., Suite 710
Chicago, IL 60612
Phone:
(312) 942-3034
Fax:
(312) 942-4168
Email:
Lisa_Boggio@rush.edu

Links

Print this Page

Off

MD, Chicago Medical School
GENA-05: "Immunogenicity, efficacy and safety of treatment with Human-cl rhFVIII in previously untreated patients with severe hemophilia A", Co Investigator CSL 627-3001: "Extension trial: Safety and efficacy of CSL 627 in the treatment of hemophilia A", Co Investigator GENA-21b: "Prospective, open-label, multicentre phase 3b study to assess the efficacy and safety of personalized prophylaxis with Human-cl rhFVIII in previously treated adult patients with severe haemophilia A", PI H13-21115: "Identification and monitoring of acute joint bleeding using ultrasonography and blood biomarkers.", Co Investigator "Hemophilia Inhibitor Research Study (HIRS) -- Phase III Inhibitor surveillance study.", Co Investigator 998HB303" Open-label, multicenter evaluation of the safety & efficacy or recombinant, long-acting coagulation factor IX Fc fusion protein (rFIXFc) in the prevention & treatment of bleeding in previously untreated patients with severe Hemophilia B, ", Co Investigator Project # CDC-RFA-DD11-1103: "Public Health Surveillance Prevention of Complications of Bleeding and Clotting Disorders", PI "COMMUNITY COUNTS-Registry for Bleeding Disorders Surveillance", PI "ATHN Data Set: Portal submission for Webtracker / Clinical Manager and the ATHN dataset.", PI ATHN2014-MLOF-2: "My Life, Our Future: GenotyPrincipal Investigatorng for patients diagnosed with hemophilia A or B.", Co Investigator 03-585: "KidsDOTT, Prospective Multi-center evaluation of the duration of therapy for thrombosis in children: ", PI CSL 627-3002: "Hemophilia A pediatric study", Co Investigator "R01 Comparative Effectiveness in the diagnosis of VWD", PI "Molecular and Clinical Biology of VWD", Co Investigator "Expression of Biomarkers in Hemophilic Arthropathy", Co Investigator "Prospective inceptional cohort study (Principal InvestigatorCS) of individuals with bleeding and clotting disorders. ", Co Investigator RB-FVIIa-006-13: "A randomized, Open-Label Study to Evaluate the PK and Safety of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc: BIIB031) Manufactured at 15K Scale and at Vial Strengths up to 6000IU in Previously Treated Subjects with Severe Hemophilia A", Co Investigator

Main Section
- Colleges
- For Professionals
- For Students
- Resources
(312) 942-7100

RUSH University
600 S. Paulina St.
Chicago, Illinois 60612

Contact Us

Accessibility, Privacy & Harassment Policies

© 2024 RUSH University